PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. The Company's portfolio consists of various subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., PMGC Capital LLC, and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. AGA Precision Systems LLC specializes in CNC machining operations.
企業コードELAB
会社名PMGC Holdings Inc
上場日Nov 21, 2023
最高経営責任者「CEO」Bensler (Graydon)
従業員数2
証券種類Ordinary Share
決算期末Nov 21
本社所在地120 Newport Center Drive
都市NEWPORT BEACH
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号92660
電話番号18884454886
ウェブサイトhttps://pmgcholdings.com/
企業コードELAB
上場日Nov 21, 2023
最高経営責任者「CEO」Bensler (Graydon)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし